BACTERIAL COMPOSITIONS FOR PREVENTION OR TREATMENT OF ATHEROSCLEROTIC DISORDERS

摘要

This invention relates to the treatment of atherosclerotic conditions through the inhibition of lipid oxidising abzymes by altering the composition of the intestinal microbial flora, for example by administering a bacterial composition to the individual. Suitable bacterial compositions may comprise, for example enteric bacteria such as lactobacilli spp, bifidobacteria spp, streptococcal spp and E. coli.